Clinical Trial Update: Palbociclib and FES PET [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating palbociclib with FES PET in breast cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Palbociclib (palbociclib)

Snippet

Sponsor: University Medical Center Groningen | Conditions: Breast Cancer | Phase 2 | Status: COMPLETED